Print

Oculus Innovative Sciences, Inc. (OCLS) Announces Licensing of Microcyn(R)-Based Products in Mexico, South/Central America and Caribbean Countries to More Pharma With $5.1 Million Up Front Payment  
8/9/2012 9:33:45 AM

MEXICO CITY and PETALUMA, Calif., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), innovator and developer of products based upon the Microcyn® Technology platform, announced today the exclusive licensing of the company's Microcyn-based human healthcare products in Mexico, South/Central America and the Caribbean to More Pharma Corporation, a 300-plus person pharmaceutical company with a commercial presence in Mexico, South/Central America and the Caribbean (www.morepharmacorp.com/eng/compania.php).
//-->